| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT04043494 |
| P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
| P17 | country | Norway | Q20 |
| Ireland | Q27 | ||
| Hungary | Q28 | ||
| Spain | Q29 | ||
| Belgium | Q31 | ||
| Finland | Q33 | ||
| Sweden | Q34 | ||
| Poland | Q36 | ||
| Denmark | Q35 | ||
| Italy | Q38 | ||
| Switzerland | Q39 | ||
| Austria | Q40 | ||
| Portugal | Q45 | ||
| Netherlands | Q55 | ||
| France | Q142 | ||
| Germany | Q183 | ||
| Slovakia | Q214 | ||
| Israel | Q801 | ||
| P582 | end time | 2027-10-31 | |
| P4135 | maximum age | 18 | |
| P1050 | medical condition | lymphoma | Q208414 |
| P1132 | number of participants | 683 | |
| P4844 | research intervention | doxorubicin | Q18936 |
| cytarabine | Q180983 | ||
| 6-thioguanine | Q385347 | ||
| (RS)-cyclophosphamide | Q408524 | ||
| vindesine | Q416660 | ||
| mercaptopurine | Q418529 | ||
| ifosfamide | Q418560 | ||
| asparaginase | Q421534 | ||
| prednisone | Q424972 | ||
| pegaspargase | Q7160547 | ||
| prednisolone | Q11426176 | ||
| P1813 | short name | LBL 2018 | |
| P859 | sponsor | University Hospital Muenster | Q1748138 |
| P580 | start time | 2019-08-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | LBL 2018 - International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma |